Paul Warner Laboratory Publications

1. Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model. Durgan K, Ali M, Warner P, Latchman YE. Cancer Immunol Immunother. 2011 Apr;60(4):547-58.
2. Humoral immunomodulatory effect of influenza vaccine in potential blood donors: implications for transfusion safety. Delaney M, Warner P, Nelson K, Gleckler C, Price T, Madeleine M. Transfus Med. 2011 Dec;21(6):378-84.
3. "ABO-incompatible Solid-organ Transplantation" PR Warner and Theresa Nester. American Society for Clinical Pathology, Pathology Patterns Reviews. June 2006, 125, S87-S94.
4. "Strategies for Transplanting the Highly Sensitized Patient: Varying the Assignment of Unacceptable Antigens" Karen A. Nelson, Danny Youngs and Paul Warner. Clinical Transplants 2007, Terasaki Foundation Laboratory, Los Angeles, CA.
5. "Nebulous Humors: Defining Alloantibodies in the 21st Century" Paul Warner. Human Immunology. August 2009, 70; 8, 623-626.
6. "Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure." Kieran N, Wang X, Perkins J, Davis C, Kendrick E, Bakthavatsalam R, Dunbar N, Warner P, Nelson K, Smith KD, Nicosia RF, Alpers CE, Leca N, Kowalewska J. J Am Soc Nephrol. 2009 Oct;20(10):2260-8.
7. "Impaired graft survival in pediatric renal transplant recipients with donor-specific antibodies detected by solid-phase assays." Verghese PS, Smith JM, McDonald RA, Schwartz SM, Nelson KA, Warner PR. Pediatr. Transplant. 2010 Sep 1;14(6):730-4.